M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures
Giuseppina Musumeci(University of Bologna), Kawthar Bouchemal(Université Paris-Sud), Maria Carla Re(University of Bologna), David Lembo(Ospedale San Luigi Gonzaga), Loı̈c Martin(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Isabella Bon(University of Bologna), Valeria Cagno(University of Lausanne), Caterina Signoretto(University of Verona), Davide Gibellini, Claudia Pastori(Vita-Salute San Raffaele University), Lucia Lopalco(Vita-Salute San Raffaele University), Erica Diani(University of Verona), Gilles Ponchel(Centre National de la Recherche Scientifique)
Cited by 11
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244